How much is a share of laboratory stock worth?
One share of LH stock can currently be purchased for approximately $304.88. How much money does Laboratory Co. of America make? Laboratory Co. of America has a market capitalization of $29.39 billion and generates $13.98 billion in revenue each year.
Should you buy laboratory co of America (LCA) stock?
The consensus among Wall Street research analysts is that investors should "buy" Laboratory Co. of America stock. View analyst ratings for Laboratory Co. of America or view top-rated stocks.
Who bought LLH stock in the last quarter?
LH stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Amundi, State Street Corp, Eagle Asset Management Inc., Dimensional Fund Advisors LP, Renaissance Technologies LLC, Alliancebernstein L.P., and Teacher Retirement System of Texas.
What was the earnings release for Laboratory Corporation of America Holdings (LH)?
Laboratory Corp. of America Holdings (NYSE:LH) announced its quarterly earnings data on Thursday, July, 25th. The medical research company reported $2.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.90 by $0.03.
Is LH stock a buy?
The 13 analysts offering 12-month price forecasts for Laboratory Corporation of America Holdings have a median target of 320.00, with a high estimate of 350.00 and a low estimate of 215.00. The median estimate represents a +46.23% increase from the last price of 218.83.
Does LH pay a dividend?
7, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on June 9, 2022 , to stockholders of record as of the close of business on May 19, 2022 .
Is labcorp publicly traded?
Is Labcorp a public organization? Yes. Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH.
Is labcorp a dividend stock?
Laboratory Corp. of America Holdings LH, +2.65% , also known as Labcorp, said Thursday that it has initiated a quarterly dividend of 72 cents a share.
Who is bigger quest or LabCorp?
For years, Quest was the largest, but LabCorp took over that spot a few years ago. Both companies are noted for growth through acquisition, and 2017 has been a very big year for LabCorp. Since 2008, LabCorp has acquired 19 companies.
Who is LabCorp owned by?
Hoffmann-La Roche merges all of its laboratory companies into one company, now called Roche Biomedical Laboratories (RBL).
Is LabCorp owned by Quest?
LabCorp and Quest Diagnostics are publicly-traded companies but they have different subsidiaries, which specialize in various protocols.
Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, February 17, 2022, and so far it has risen 0.97%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices.
Support, Risk & Stop-loss
Laboratory Corp of America Holdings finds support from accumulated volume at $261.92 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Is Laboratory Corporation of America Holdings stock A Buy?
Laboratory Corp of America Holdings holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Insiders are neutral buying more shares than they are selling in Laboratory Corp of America Holdings
In the last 100 trades there were 67.46 thousand shares bought and 59.71 thousand shares sold. The last trade was done 5 days ago by Neupert Peter M who bough 600 shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
About Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates through two segments, LabCorp Diagnostics and Covance Drug Development.
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
Labcorp Completes Acquisition of Personal Genome Diagnostics
BURLINGTON, N.C., February 21, 2022--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products.
LabCorp (LH) Expands Clinical Laboratory Services With New Pact
LabCorp's (LH) recent collaboration will enable it to administer Ascension's hospital-based laboratories in 10 states and purchase select assets of the health system's outreach laboratory business.